1-methyl-3-isobutylxanthine has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Roderick, JE | 1 |
Gallagher, KM | 1 |
Murphy, LC | 1 |
O'Connor, KW | 1 |
Tang, K | 1 |
Zhang, B | 1 |
Brehm, MA | 1 |
Greiner, DL | 1 |
Yu, J | 1 |
Zhu, LJ | 1 |
Green, MR | 1 |
Kelliher, MA | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tum | 2021 |